For the many young adults living with diabetes, health insurance coverage transitions are not only stressful; they can also ...

The Centers for Medicare and Medicaid Services (CMS) proposed new limits on how states use provider taxes to finance their ...

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...

By simulating various scenarios, predictive models help public health officials weigh the trade-offs between different ...

Now is the time for policy makers, payers, health systems, and clinicians to act decisively by extending AHCaH, evaluating ...

Massachusetts’ new health care reform expands the authority of the state to intervene prior to significant changes to the ...

During the COVID-19 pandemic, suppression of scientific debate and the marginalization of dissenting voices weakened public ...

Delaying Medicare’s ability to negotiate prices on small-molecule drugs until 13 years after FDA approval will decrease the ...

Unless Congress acts to renew them by the end of this year, enhanced premium subsidies for the Affordable Care Act’s ...

As health scholars at the American Enterprise Institute, the Brookings Institution, and the Bipartisan Policy Center, we ...

By May 5, 2025, the Trump administration will file its first brief in Missouri v. Food and Drug Administration, staking out a ...

Health Affairs' Senior Deputy Editor Rob Lott interviews Eric Topol, Executive Vice President of Scripps Research, on his new ...